Physician profile
Erinn K Coe
NPI 1528529591
$1,215.30
in general payments reported to CMS, 2019-2025
7 companies · $707 in 2025
The $707 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.33 · 2022: $20.55 · 2023: $172 · 2024: $284 · 2025: $707.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,163.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $569.96 | 2023-2025 | Rinvoq |
| Astrazeneca Pharmaceuticals LP | $255.77 | 2023-2025 | Saphnelo |
| Amgen INC. | $166.35 | 2023-2025 | Tavneos, Uplizna |
| Janssen Biotech, INC. | $89.75 | 2025 | Simponi Aria, Tremfya |
| Novartis Pharmaceuticals Corporation | $56.72 | 2024 | |
| Aurinia Pharma U.S., INC. | $45.42 | 2022-2023 | |
| Regeneron Healthcare Solutions, INC. | $31.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erinn Coe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.